Ernexa Therapeutics Inc.
ERNA
$0.29
$0.001.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.88M | 3.05M | 4.32M | 1.92M | 1.73M |
| Total Receivables | 845.00K | 153.00K | 154.00K | 156.00K | 437.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 404.00K | 179.00K | 323.00K | 137.00K | 186.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.13M | 3.38M | 4.79M | 2.21M | 2.35M |
|
|
|||||
| Total Current Assets | 3.13M | 3.38M | 4.79M | 2.21M | 2.35M |
| Net Property, Plant & Equipment | 547.00K | 633.00K | 631.00K | 686.00K | 755.00K |
| Long-term Investments | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Goodwill | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 110.00K | 116.00K | 117.00K | 118.00K | 118.00K |
| Total Assets | 5.83M | 6.17M | 7.58M | 5.06M | 5.27M |
|
|
|||||
| Total Accounts Payable | 1.13M | 958.00K | 1.32M | 1.28M | 1.72M |
| Total Accrued Expenses | 562.00K | 829.00K | 908.00K | 1.09M | 684.00K |
| Short-term Debt | -- | -- | -- | 2.25M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 213.00K | 206.00K | 217.00K | 213.00K | 207.00K |
| Total Finance Division Other Current Liabilities | 1.21M | 151.00K | 207.00K | 5.61M | 326.00K |
| Total Other Current Liabilities | 1.21M | 151.00K | 207.00K | 5.61M | 326.00K |
| Total Current Liabilities | 3.11M | 2.14M | 2.65M | 10.44M | 2.94M |
|
|
|||||
| Total Current Liabilities | 3.11M | 2.14M | 2.65M | 10.44M | 2.94M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 2.25M | -- |
| Capital Leases | 277.00K | 346.00K | 376.00K | 419.00K | 477.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 43.00K | 112.00K | 113.00K | 152.00K | 153.00K |
| Total Liabilities | 3.43M | 2.60M | 3.14M | 11.01M | 3.57M |
|
|
|||||
| Common Stock & APIC | 248.04M | 247.70M | 247.33M | 233.79M | 233.24M |
| Retained Earnings | -245.64M | -244.13M | -242.89M | -239.74M | -231.54M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.40M | 3.57M | 4.44M | -5.95M | 1.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | 2.40M | 3.57M | 4.44M | -5.95M | 1.70M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.40M | 3.57M | 4.44M | -5.95M | 1.70M |
|
|
|||||